What if we could help the body manage inflammation before it becomes dangerous?
At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
More from Youtube
- 0:36Can a Diabetes Med Help Regrow Bone? | Breakthroughs Can’t WaitWhat if we could regenerate bone using a medication already on the market?At the University of Maryland, Baltimore, researchers are exploring how metformin — a drug commonly used to treat diabetes — could be repurposed to stimulate bone growth and healing.This is just one of many NIH-funded breakthroughs at UMB with the power to transform medicine and save lives.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #BoneRegeneration #MetforminResearch #DiabetesDrugInnovation #MedicalBreakthroughs #UMBResearch #NIHfunding #TissueEngineering
- 20:45Seven Students | One Conversation: Full VideoCongratulations to the University of Maryland, Baltimore Class of 2025. This year, we present Seven Students, One Conversations, speaking to graduates from each of UMB's seven schools.Provost and Executive Vice President Roger Ward, EdD, JD, MSL, MPA, asks these students about their experiences at UMB as they pause, reflect and look forward to their futures after graduation.
